Zdrowie i gospodarka · 11/01/2012
FDA Clears AVALIDE Tablets for Approval
The FDA has determined that AVALIDE, a combination of hydrochlorothiazide and irbesartan, oral tablets in various strengths, were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.